Voyager Therapeutics (VYGR) Other financing activities (2018 - 2025)
Voyager Therapeutics recorded quarterly Other financing activities of $434000.0 in Q2 2025, down 32.08% quarter-over-quarter from $639000.0 in Q2 2024, and down 32.08% year-over-year from $639000.0 in Q2 2024.
Voyager Therapeutics' Other financing activities history runs 8 years deep, the most recent figure standing at $434000.0 for Q2 2025.
- In Q2 2025, Other financing activities fell 32.08% year-over-year to $434000.0; the TTM figure through Jun 2025 stood at $1.8 million (down 7.49% YoY), while the FY2025 annual figure was $549000.0, down 53.16% from the prior year.
- Other financing activities came in at $434000.0 for Q2 2025 at Voyager Therapeutics, down from $639000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $639000.0 in Q2 2024 to a low of $313000.0 in Q2 2022.
- A 5-year average of $476800.0 and a median of $434000.0 in 2025 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities sank 46.03% in 2022 and soared 52.87% in 2024, its largest moves.
- Voyager Therapeutics' Other financing activities stood at $580000.0 in 2021, then tumbled by 46.03% to $313000.0 in 2022, then surged by 33.55% to $418000.0 in 2023, then surged by 52.87% to $639000.0 in 2024, then plunged by 32.08% to $434000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $434000.0, $639000.0, and $418000.0 for Q2 2025, Q2 2024, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 434,000.00 |
| Jun 30, 2025 | 434,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Jun 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 418,000.00 |
| Jun 30, 2022 | 313,000.00 |
| Jun 30, 2022 | 313,000.00 |
| Jun 30, 2021 | 580,000.00 |
| Jun 30, 2021 | 580,000.00 |
| Jun 30, 2020 | 638,000.00 |
| Jun 30, 2020 | 638,000.00 |
| Jun 30, 2019 | 471,000.00 |
| Jun 30, 2019 | 471,000.00 |
| Sep 30, 2018 | 424,000.00 |
| Sep 30, 2018 | 424,000.00 |
| Mar 31, 2018 | 418,000.00 |
| Mar 31, 2018 | 418,000.00 |